Tumor angiogenesis represents one of the hallmarks in cancer, and differential expression of important mediators of this process, in particular vascular endothelial growth factor (VEGF), has been associated with tumor progression and poor prognosis in several tumor types, including BC (Berns et al., 2003; Manders et al., 2002). The gene discussed is VEGFA; the disease is breast cancer.